Recordati reported EUR192.76M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
GlaxoSmithKline GBP 2.12B 558M Mar/2026
Hikma Pharmaceutical USD 288M 149M Dec/2025
Orion EUR 91.9M 18.8M Mar/2026
Sanofi EUR 2.33B 419M Mar/2026